Search

Author/Creator Ramphal, Reuben

1. 1257. Re-Evaluation of Cefepime or Piperacillin-Tazobactam to Decrease Use of Carbapenems in ESBL-Producing Enterobacterales Urinary Tract Infections (REDUCE-UTI). (4th December 2021)

Authors:
Branton, Alexander C; Vu, Catherine H; Veena, Venugopalan; Santevecchi, Barbara A; Ramphal, Reuben; Cherabuddi, Kartikeya; Manohar, Tanvi; Rodriguez, David; Tello, Andrea; DeSear, Kathryn
Journal:
Open forum infectious diseases
Issue:
Volume 8(2021)Supplement 1
Page Start:
S717
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Pseudomonas aeruginosa proteolytically alters the interleukin 22-dependent lung mucosal defense. Issue 6 (18th August 2017)

Authors:
Guillon, Antoine; Brea, Deborah; Morello, Eric; Tang, Aihua; Jouan, Youenn; Ramphal, Reuben; Korkmaz, Brice; Perez-Cruz, Magdiel; Trottein, Francois; O'Callaghan, Richard J.; Gosset, Philippe; Si-Tahar, Mustapha
Journal:
Virulence
Issue:
Volume 8:Issue 6(2017)
Page Start:
810
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Re-evaluation of cefepime or piperacillin-tazobactam to decrease use of carbapenems in extended-spectrum beta-lactamase–producing Enterobacterales bloodstream infections (REDUCE-BSI). Issue 1 (11th March 2022)

Authors:
Vu, Catherine H.; Venugopalan, Veena; Santevecchi, Barbara A.; Voils, Stacy A.; Ramphal, Reuben; Cherabuddi, Kartikeya; DeSear, Kathryn
Journal:
Antimicrobial stewardship & healthcare epidemiology
Issue:
Volume 2:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗